img

Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Age related macular degeneration (AMD) is a medical condition that results in loss of vision in the central visual field, owing to damage to the retina. This is usually an age-related disorder, which affects adults with the age 50 and above. Diabetic retinopathy is an ophthalmic disorder, in which blindness occurrs due to complications in diabetes.
Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from 50-60 Years Old and 60-70 Years Old are the major drivers for the industry.
The North American region is the most lucrative market, owing to large number of elderly population in the U.S. However, European and Asia-Pacific regions are considered as the most promising markets in the upcoming period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan
Segment by Type
Macular Degeneration Drugs
Diabetic Retinopathy Drugs

Segment by Application


50-60 Years Old
60-70 Years Old
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs introduction, etc. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Overview
1.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Overview
1.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment by Type
1.2.1 Macular Degeneration Drugs
1.2.2 Diabetic Retinopathy Drugs
1.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Type
1.3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size Review by Type (2018-2024)
1.3.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2018-2024)
1.4.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Type (2018-2024)
2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Competition by Company
2.1 Global Top Players by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (2018-2024)
2.2 Global Top Players by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue (2018-2024)
2.3 Global Top Players by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price (2018-2024)
2.4 Global Top Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Competitive Situation and Trends
2.5.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market
2.8 Key Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Status and Outlook by Region
3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size by Region
3.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2018-2024)
3.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2018-2024)
3.2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Region
3.3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Application
4.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segment by Application
4.1.1 50-60 Years Old
4.1.2 60-70 Years Old
4.1.3 Others
4.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application
4.2.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size Review by Application (2018-2024)
4.2.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2018-2024)
4.3.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Breakdown by Application (2018-2024)
5 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Country
5.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size by Country
5.1.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2018-2024)
5.1.3 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2018-2024)
5.2 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Country
5.2.1 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2024-2034)
6 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Country
6.1 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size by Country
6.1.1 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2018-2024)
6.1.3 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2018-2024)
6.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Country
6.2.1 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Region
7.1 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Region (2024-2034)
8 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Country
8.1 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size by Country
8.1.1 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2018-2024)
8.1.3 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2018-2024)
8.2 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Country
8.2.1 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs by Country
9.1 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
10.1.5 Novartis Recent Development
10.2 Bayer Healthcare
10.2.1 Bayer Healthcare Company Information
10.2.2 Bayer Healthcare Introduction and Business Overview
10.2.3 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
10.2.5 Bayer Healthcare Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
10.3.5 Roche Recent Development
10.4 Neurotech Pharmaceuticals
10.4.1 Neurotech Pharmaceuticals Company Information
10.4.2 Neurotech Pharmaceuticals Introduction and Business Overview
10.4.3 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
10.4.5 Neurotech Pharmaceuticals Recent Development
10.5 Regeneron Pharmaceuticals
10.5.1 Regeneron Pharmaceuticals Company Information
10.5.2 Regeneron Pharmaceuticals Introduction and Business Overview
10.5.3 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
10.5.5 Regeneron Pharmaceuticals Recent Development
10.6 Allergan
10.6.1 Allergan Company Information
10.6.2 Allergan Introduction and Business Overview
10.6.3 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Products Offered
10.6.5 Allergan Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industrial Chain Analysis
11.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Dynamics
11.4.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industry Trends
11.4.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Drivers
11.4.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Challenges
11.4.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors
12.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Macular Degeneration Drugs
Table 2. Major Company of Diabetic Retinopathy Drugs
Table 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2024) & (K MT)
Table 5. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2024) & (US& Million)
Table 7. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share in Value by Type (2018-2024)
Table 8. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Type (2018-2024) & (USD/MT)
Table 9. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2024-2034) & (K MT)
Table 10. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type (2024-2034)
Table 13. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Type (2024-2034) & (USD/MT)
Table 14. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2024) & (K MT)
Table 15. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT) by Type (2018-2024)
Table 17. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT) by Type (2018-2024)
Table 19. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT) by Type (2018-2024)
Table 21. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT) by Type (2018-2024)
Table 23. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Company (2018-2024) & (K MT)
Table 25. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Share by Company (2018-2024)
Table 26. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue Share by Company (2018-2024)
Table 28. Global Market Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Company (2018-2024) & (USD/MT)
Table 29. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs as of 2022)
Table 32. Date of Key Manufacturers Enter into Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market
Table 33. Key Manufacturers Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2018-2024) & (K MT)
Table 37. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Region (2018-2024)
Table 40. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 41. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2024-2034) & (K MT)
Table 42. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Region (2024-2034)
Table 45. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 46. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) & (K MT)
Table 48. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application (2018-2024)
Table 51. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Application (2018-2024) & (USD/MT)
Table 52. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2024-2034) & (K MT)
Table 53. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application (2024-2034)
Table 56. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price by Application (2024-2034) & (USD/MT)
Table 57. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) (K MT)
Table 58. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) (K MT)
Table 60. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) (K MT)
Table 62. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) (K MT)
Table 64. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) (K MT)
Table 66. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2018-2024) & (K MT)
Table 68. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Country (2018-2024)
Table 71. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2024-2034) & (K MT)
Table 72. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2018-2024) & (K MT)
Table 76. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2024-2034) & (K MT)
Table 80. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2018-2024) & (K MT)
Table 84. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2024-2034) & (K MT)
Table 88. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2018-2024) & (K MT)
Table 92. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2024-2034) & (K MT)
Table 96. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2018-2024) & (K MT)
Table 100. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2024-2034) & (K MT)
Table 104. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Country (2024-2034)
Table 107. Novartis Company Information
Table 108. Novartis Introduction and Business Overview
Table 109. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 110. Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product
Table 111. Novartis Recent Development
Table 112. Bayer Healthcare Company Information
Table 113. Bayer Healthcare Introduction and Business Overview
Table 114. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product
Table 116. Bayer Healthcare Recent Development
Table 117. Roche Company Information
Table 118. Roche Introduction and Business Overview
Table 119. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Roche Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product
Table 121. Roche Recent Development
Table 122. Neurotech Pharmaceuticals Company Information
Table 123. Neurotech Pharmaceuticals Introduction and Business Overview
Table 124. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Neurotech Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product
Table 126. Neurotech Pharmaceuticals Recent Development
Table 127. Regeneron Pharmaceuticals Company Information
Table 128. Regeneron Pharmaceuticals Introduction and Business Overview
Table 129. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. Regeneron Pharmaceuticals Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product
Table 131. Regeneron Pharmaceuticals Recent Development
Table 132. Allergan Company Information
Table 133. Allergan Introduction and Business Overview
Table 134. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Allergan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product
Table 136. Allergan Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Trends
Table 140. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Drivers
Table 141. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Challenges
Table 142. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Restraints
Table 143. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Distributors List
Table 144. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Picture
Figure 2. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Macular Degeneration Drugs
Figure 6. Global Macular Degeneration Drugs Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Diabetic Retinopathy Drugs
Figure 8. Global Diabetic Retinopathy Drugs Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share by Type in 2022 & 2034
Figure 11. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2022
Figure 12. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2022
Figure 13. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2022
Figure 14. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2022
Figure 17. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Revenue in 2022
Figure 23. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of 50-60 Years Old
Figure 25. Global 50-60 Years Old Sales YoY Growth (2018-2034) & (K MT)
Figure 26. Product Picture of 60-70 Years Old
Figure 27. Global 60-70 Years Old Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Product Picture of Others
Figure 29. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share by Application in 2022 & 2034
Figure 32. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2022
Figure 33. North America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2022
Figure 34. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2022
Figure 35. Europe Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2022
Figure 38. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturing Cost Structure
Figure 43. Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed